MOH Stock Surges 9.2% With A 5-day Winning Spree On Michael Burry Endorsement
Molina Healthcare (MOH) stock hit day 5-day winning streak, with cumulative gains over this period amounting to a 9.2%. The company market cap has surged by about $787 Mil over the last 5 days, and currently stands at $9.4 Bil.
The stock has YTD (year-to-date) return of 2.8% compared to 0.2% for S&P 500. This calls for a re-evaluation of the stock’s valuation to find out whether this is an opportunity, or a trap.
What Triggered The Rally?
[1] Michael Burry’s Bullish Call
- CSCO Stock: Two Signals Pointing The Same Way
- Decoding AVGO Stock’s Premium Valuation
- What Could Push NVDA Stock Higher From Here?
- Cash Machine Trading Cheap – Inspire Medical Systems Stock Set to Run?
- Five-Year Tally: AT&T Stock Delivers $58 Bil Gain
- Years of Rewards: $43 Bil From Caterpillar Stock
- Famed investor suggested MOH could be an acquisition target
- Compared the opportunity to Warren Buffett’s GEICO investment
- Impact: Sharp Price Increase, Heightened Investor Interest
[2] Sustained Institutional Accumulation
- Cobalt Capital Management disclosed a new, significant position
- Scion Asset Management, run by Burry, also disclosed a new position
- Impact: Increased Buying Pressure, Positive Market Sentiment
Opportunity or Trap?
Below is our take on valuation.
There are only a couple of things to fear in MOH stock given its overall Moderate operating performance and financial condition. Taken together with its Very Low valuation, this makes the stock look Attractive (For details, see Buy or Sell MOH).
But here is the real interesting point.
You are reading about this 9.2% move after it happened. The market has already priced in the news. To catch the next winner before the headlines, you need predictive signals, not notifications. Our High Quality Portfolio has flagged 5 new opportunities that haven not surged yet.
Returns vs S&P 500
The following table summarizes the return for MOH stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | MOH | S&P 500 |
|---|---|---|
| 1D | 2.8% | 0.2% |
| 5D (Current Streak) | 9.2% | -1.1% |
| 1M (21D) | 22.3% | 0.4% |
| 3M (63D) | -8.1% | 2.1% |
| YTD 2026 | 2.8% | 0.2% |
| 2025 | -40.4% | 16.4% |
| 2024 | -19.4% | 23.3% |
| 2023 | 9.4% | 24.2% |
However, big gains can follow sharp reversals – but how has MOH behaved after prior drops? See MOH Dip Buyer Analysis to learn more.
Gains and Losses Streaks: S&P 500 Constituents
There are currently 7 S&P constituents with 3 days or more of consecutive gains and 111 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 2 | 49 |
| 4D | 2 | 30 |
| 5D | 1 | 24 |
| 6D | 2 | 2 |
| 7D or more | 0 | 6 |
| Total >=3 D | 7 | 111 |
Key Financials for Molina Healthcare (MOH)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenues | $34.1 Bil | $40.6 Bil |
| Operating Income | $1.6 Bil | $1.7 Bil |
| Net Income | $1.1 Bil | $1.2 Bil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ2 | 2025 FQ3 |
|---|---|---|
| Revenues | $11.4 Bil | $11.5 Bil |
| Operating Income | $373.0 Mil | $137.0 Mil |
| Net Income | $255.0 Mil | $79.0 Mil |
While MOH stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.